Matthieu Resche-Rigon

Summary

Country: France

Publications

  1. doi request reprint Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes
    Matthieu Resche-Rigon
    Biostatistical Department, U717 INSERM, AP HP, Paris 7 University, Saint Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France
    Clin Trials 5:595-606. 2008
  2. pmc Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases
    Matthieu Resche-Rigon
    Departement de Biostatistique et Informatique Medicale, Hopital Saint Louis, AP HP, Paris 75010, France
    BMC Blood Disord 12:10. 2012
  3. doi request reprint Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study
    Sarah Zohar
    Inserm U717, Departement de Biostatistique et Informatique Medicale, Hopital Saint Louis, Paris 7 University, France
    Clin Trials 10:414-21. 2013
  4. pmc Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size
    Romain Pirracchio
    Service de Biostatistique et Information Medicale, Hopital Saint Louis, UMR S717 Inserm Sorbonne Paris Cité, Universite Paris Diderot, 1 avenue Claude Vellefaux, Paris 75010, France
    BMC Med Res Methodol 12:70. 2012

Detail Information

Publications4

  1. doi request reprint Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes
    Matthieu Resche-Rigon
    Biostatistical Department, U717 INSERM, AP HP, Paris 7 University, Saint Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France
    Clin Trials 5:595-606. 2008
    ..However, in certain vulnerable populations, such as neonates or infants, there is an heightened requirement for safety, precluding randomization...
  2. pmc Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases
    Matthieu Resche-Rigon
    Departement de Biostatistique et Informatique Medicale, Hopital Saint Louis, AP HP, Paris 75010, France
    BMC Blood Disord 12:10. 2012
    ..abstract:..
  3. doi request reprint Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study
    Sarah Zohar
    Inserm U717, Departement de Biostatistique et Informatique Medicale, Hopital Saint Louis, Paris 7 University, France
    Clin Trials 10:414-21. 2013
    ..However, this adaptive statistical approach also can be applied easily to dose-finding experiments in phase II trials...
  4. pmc Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size
    Romain Pirracchio
    Service de Biostatistique et Information Medicale, Hopital Saint Louis, UMR S717 Inserm Sorbonne Paris Cité, Universite Paris Diderot, 1 avenue Claude Vellefaux, Paris 75010, France
    BMC Med Res Methodol 12:70. 2012
    ..However, the relative performance of the two mainly recommended PS methods, namely PS-matching or inverse probability of treatment weighting (IPTW), have not been studied in the context of small sample sizes...